MODIFICATION
R -- Assistance to the Development Therapeutics Program
- Notice Date
- 3/12/2008
- Notice Type
- Modification
- NAICS
- 561110
— Office Administrative Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions-Treatment and Support Branch, Bldg 244, Room 112, Frederick, MD, 21702, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- N02-CM-87001-45
- Response Due
- 4/23/2008
- Archive Date
- 7/1/2009
- Point of Contact
- Kathy Giuliano, Contract Specialist, Phone (301) 435-3821, Fax (301) 402-6699
- E-Mail Address
-
kg109o@nih.gov
- Small Business Set-Aside
- Total Small Business
- Description
- The Developmental Therapeutics Program (DTP) of the National Cancer Institute?s Division of Cancer Treatment and Diagnosis (DCTD) is seeking an organization to provide assistance in specific areas of its extramural Program, with particular emphasis on the functions of the network of action/decision points committees that guide the progression of potentially useful anticancer agents through the entire preclinical drug discovery and development process. The activities of the DTP Program extend from the acquisition and input of new natural and synthetic materials into the system through the initial and secondary evaluations and subsequent preclinical development phases leading to approval for Phase I clinical trials. The scientific disciplines involved include chemistry, biology, pharmacology, toxicology and the pharmaceutical sciences, and technical expertise in the management of computerized databases. The Contractor will have access to proprietary information on compounds acquired by the NCI and the Contractor shall be required to treat all information obtained under this contract as strictly confidential. The Government will provide the Contractor with guidelines governing this requirement. In the performance of these services, an adverse drug reaction or event may require an immediate response by the Contractor. It is essential that the Contractor be capable of providing such an immediate response, which generally should be approximately one hour. The Contractor's facility must be located in close proximity to the committee meetings in the Rockville, Bethesda area to facilitate such an immediate response. Since this contract involves the use of information on commercially, confidential compounds, pharmaceutical and chemical companies are excluded from participating. A pharmaceutical or chemical company is defined as an organization that sells drugs and/or chemicals to the general public for profit. It is anticipated that a single level of effort award will be made for a five-year period of performance with incremental funding each year. Offerors will be invited to submit proposals for 5,800 direct labor hours annually for Years 1 through 5. This is 100% small business set-aside under NAICS Code No. 561110 with a size standard of 500 employees and $6.5 Million (See Note 1). The solicitation is scheduled for electronic release on or about March 3, 2008. The RFP may be accessed through the internet address http://rcb.nci.nih.gov/; it is the offeror's responsibility to monitor the internet site for the release of this solicitation and amendments, if any. POTENTIAL OFFEROR'S WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICIATION AND AMENDMENTS. Point of Contact: Kathleen Giuliano, Contract Specialist, at e-mail: giuliank@mail.nih.gov/Fax: 301-228-4240; Telephone: 301-228-4216. No Collect Calls will be accepted. ALL QUESTIONS MUST BE MADE IN WRITING.
- Record
- SN01530477-W 20080314/080312223551 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |